RMD Earnings ResMed
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q3 2026 | 2026-03-31 | 7.79 | 2026-05-01 | 10-Q |
| Q2 2026 | 2025-12-31 | 5.05 | 2026-01-30 | 10-Q |
| Q1 2026 | 2025-09-30 | 2.37 | 2025-10-31 | 10-Q |
| FY 2025 | 2025-06-30 | 9.51 | 2025-08-08 | 10-K |
| Q3 2026 | 2025-03-31 | 6.93 | 2026-05-01 | 10-Q |
| Q2 2026 | 2024-12-31 | 4.45 | 2026-01-30 | 10-Q |
| Q1 2026 | 2024-09-30 | 2.11 | 2025-10-31 | 10-Q |
| FY 2025 | 2024-06-30 | 6.92 | 2025-08-08 | 10-K |
| Q3 2025 | 2024-03-31 | 4.94 | 2025-04-24 | 10-Q |
| Q2 2025 | 2023-12-31 | 2.90 | 2025-01-31 | 10-Q |
| Q1 2025 | 2023-09-30 | 1.49 | 2024-10-25 | 10-Q |
| FY 2025 | 2023-06-30 | 6.09 | 2025-08-08 | 10-K |
| Q3 2024 | 2023-03-31 | 4.53 | 2024-04-26 | 10-Q |
| Q2 2024 | 2022-12-31 | 2.95 | 2024-01-25 | 10-Q |
| Q1 2024 | 2022-09-30 | 1.43 | 2023-10-27 | 10-Q |
| FY 2024 | 2022-06-30 | 5.30 | 2024-08-09 | 10-K |
| Q3 2023 | 2022-03-31 | 3.97 | 2023-04-28 | 10-Q |
| Q2 2023 | 2021-12-31 | 2.76 | 2023-01-27 | 10-Q |
| Q1 2023 | 2021-09-30 | 1.39 | 2022-10-28 | 10-Q |
| FY 2023 | 2021-06-30 | 3.24 | 2023-08-11 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.